Samir earned his MD and PhD in Immunology from the Perelman School of Medicine at the University of Pennsylvania, where he was the recipient of the Saul Winegrad Award for outstanding dissertation. His thesis uncovered a novel immune evasion mechanism in solid tumors and was published in Cell. Concurrent with graduate school, Samir consulted for …
Department: Investment Professionals
Behzad Aghazadeh
Dr. Behzad Aghazadeh, PhD is the Managing Partner and Portfolio Manager of Avoro Capital. He has over 25 years of experience in the biopharmaceutical industry spanning scientific research, management consulting, institutional investing, and board leadership. Behzad received his master’s degree in Physics from the Ludwig-Maximilians-University and a PhD from Cornell University in Biochemistry & Biophysics. …
Max Isberg
Max holds a B.S. from Tufts University. He graduated Summa Cum Laude in 2016, majoring in math and economics. After graduating, he worked for Apex Capital Holdings, where he was a trader/analyst managing a long/short equity portfolio focused on biotechnology and pharmaceutical names. Max joined Avoro Capital in 2019 and will focus on quantitative analysis …
Robert Raphael
Robert holds a BA Cum Laude in Political Science from the University of Rochester. Robert has over 10 years of trading and operations experience. Prior to joining Avoro Capital in 2019, Robert helped launch and was Head Trader at Jafra Capital Management. Before Jafra, he was a Trader at Jericho Capital Asset Management. He began …
Matthew Canver
Matthew received a BSE in Bioengineering from the University of Pennsylvania and earned his MD/PhD from Harvard Medical School. Matthew completed one year of residency in Clinical Pathology at New York Presbyterian Hospital/Weill Cornell Medicine. His PhD involved development of a CRISPR-based gene therapy approach to sickle cell disease. Matthew joined Avoro Capital in 2019 …
+1 212.937.4970